Zhongling Wang

1.3k citations
41 papers · 1.1k indexed · h-index 17
Topics
Nanoplatforms for cancer theranostics (16 papers)Nanoparticle-Based Drug Delivery (14 papers)Advanced biosensing and bioanalysis techniques (4 papers)

In The Last Decade

Zhongling Wang

40 papers receiving 1.1k citations

Peers

Zhongling Wang
Comparison fields: 5 of 92
  • Biomedical Engineering 681
  • Biomaterials 500
  • Materials Chemistry 334
  • Molecular Biology 284
  • Radiology, Nuclear Medicine and Imaging 102
Replace Linji Gong with:
Linji Gong China
Donghoon Lee United States
Changqiang Wu China
Dongkyu Kim South Korea
Jingchao Li China
Erhan İ. Altınoğlu United States
Zhongping Chen China
Jie Xing China
Debabrata Maiti China
Zhongling Wang relative to Linji Gong China Linji Gong's profile →
Citations per field
00.5×3.7×
Linji Gong · 1×
Citations per year

Countries citing papers authored by Zhongling Wang

Since Specialization
Citations

This map shows the geographic impact of Zhongling Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongling Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongling Wang more than expected).

Fields of papers citing papers by Zhongling Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongling Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongling Wang. The network helps show where Zhongling Wang may publish in the future.

Co-authorship network of co-authors of Zhongling Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongling Wang. A scholar is included among the top collaborators of Zhongling Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongling Wang. Zhongling Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 8
4 2
5 5
6 2
7 22
8 64
9 120
10 1
11 171
12 21
13 34
14 26
15 13
16 30
17 23
18 6
19 20
20 2

About Zhongling Wang

Zhongling Wang is a scholar working on Biomaterials, Biomedical Engineering and Biological Psychiatry, having authored 41 papers that have together received 1.1k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (16 papers), Nanoparticle-Based Drug Delivery (14 papers) and Advanced biosensing and bioanalysis techniques (4 papers). The work is most often cited by research in Biomaterials (500 citations), Biomedical Engineering (681 citations) and Materials Chemistry (334 citations). Zhongling Wang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xiangdong Xue, Yuanpei Li, Hongwei Lu, Tzu‐yin Lin, Ye Yuan, Ziwei Lu, Yee Huang, Hao Wu, Zhao Ma and Bei Jia. Their work appears in journals such as Advanced Materials, Nature Communications and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026